InvestorsHub Logo
Followers 11
Posts 292
Boards Moderated 0
Alias Born 03/11/2011

Re: dr_lowenstein post# 33488

Tuesday, 10/13/2015 11:04:15 PM

Tuesday, October 13, 2015 11:04:15 PM

Post# of 48316
of course, which is why I think they have a great chance at improving Keytruda. Looking at past studies done for Interleukin-12, which is extremely toxic, it makes me think of Keytruda's side effects. Oncosec has removed all the toxicity from the dangerous but very much needed IL-12 cytokine, allowing its used to raise TIL's while lowering tumor inflammation. And who better to do it, if not the same doctor that began Keytruda.